Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros












Intervalo de año de publicación
1.
Asian Pac J Cancer Prev ; 18(8): 2171-2177, 2017 08 27.
Artículo en Inglés | MEDLINE | ID: mdl-28843252

RESUMEN

Background: Overexpression of proangiogenic vascular endothelial growth factor A family VEGFAxxx is associated with tumor growth and metastasis. The role of the alternatively spliced antiangiogenic family VEGFAxxxb is poorly investigated in head and neck squamous cell carcinomas (HNSCCs). The antiangiogenic isoform binds to bevacizumab and its expression level could influence the treatment response and progression-free survival. In this study, the relative expression of VEGFAxxx and VEGFA165b isoforms and splicing regulatory factors genes was investigated in a series of HNSCCs. Methods: VEGFAxxx, VEGFA165b, SRSF6, SRSF5, SRSF1 and SRPK1 gene expression was quantified by quantitative real time PCR in 53 tissue samples obtained by surgery from HNSCC patients. Protein expression was evaluated by immunohistochemistry. Results: VEGFAxxx and VEGFA165b were overexpressed in HNSCCs. Elevated protein expression was also confirmed. However, VEGFA isoforms demonstrated differential expression according to anatomical sites. VEGFAxxx was overexpressed in pharyngeal tumors while the VEGFA165b isoform was up-regulated in oral tumors. The VEGFA165b isoform was also positively correlated with expression of the splicing regulatory genes SRSF1, SRSF6 and SRSF5. Conclusions: We concluded that VEGFAxxx and VEGFA165b isoforms are overexpressed in HNSCCs and the splicing regulatory factors SRSF1, SRSF6, SRSF5 and SRPK1 may contribute to alternative splicing of the VEGFA gene. The findings for the differential expression of the antiangiogenic isoform in HNSCCs could facilitate effective therapeutic strategies for the management of these tumors.

2.
Mol Biol Rep ; 39(12): 10157-65, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22972152

RESUMEN

Human N-myc downstream-regulated gene 1 (NDRG1) is a metastasis suppressor gene with several potential functions, including cell differentiation, cell cycle regulation and response to hormones, nickel and stress. The purpose of this study was to investigate the immunoexpression of NDRG1 in oral and oropharyngeal squamous cell carcinomas searching for its role in the clinical course of these tumors. We investigated immunohistochemical expression of NDRG1 protein in 412 tissue microarray cores of tumor samples from 103 patients with oral and oropharyngeal squamous cell carcinomas and in 110 paraffin-embedded surgical margin sections. The results showed NDRG1 up-regulation in 101/103 (98.1 %) tumor samples, but no expression in any normal tissue sample. Western blot assays confirmed the immunohistochemical findings, suggesting that lower levels of NDRG1 are associated with a high mortality rate. NDRG1 overexpression was related to long-term specific survival (HR = 0.38; p = 0.009), whereas the presence of lymph-node metastasis showed the opposite association with survival (HR = 2.45; p = 0.013). Our findings reinforce the idea that NDRG1 plays a metastasis suppressor role in oral and oropharyngeal squamous cell carcinomas and may be a useful marker for these tumors.


Asunto(s)
Carcinoma de Células Escamosas/metabolismo , Proteínas de Ciclo Celular/metabolismo , Expresión Génica , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Neoplasias de la Boca/metabolismo , Neoplasias Orofaríngeas/metabolismo , Adulto , Anciano , Biomarcadores de Tumor/genética , Biomarcadores de Tumor/metabolismo , Carcinoma de Células Escamosas/mortalidad , Carcinoma de Células Escamosas/secundario , Proteínas de Ciclo Celular/genética , Femenino , Humanos , Péptidos y Proteínas de Señalización Intracelular/genética , Estimación de Kaplan-Meier , Metástasis Linfática , Masculino , Persona de Mediana Edad , Neoplasias de la Boca/mortalidad , Neoplasias de la Boca/patología , Neoplasias Orofaríngeas/mortalidad , Neoplasias Orofaríngeas/patología , Pronóstico , Modelos de Riesgos Proporcionales , Análisis de Matrices Tisulares
3.
Int J Oncol ; 40(4): 1180-8, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-22227861

RESUMEN

The search for molecular markers to improve diagnosis, individualize treatment and predict behavior of tumors has been the focus of several studies. This study aimed to analyze homeobox gene expression profile in oral squamous cell carcinoma (OSCC) as well as to investigate whether some of these genes are relevant molecular markers of prognosis and/or tumor aggressiveness. Homeobox gene expression levels were assessed by microarrays and qRT-PCR in OSCC tissues and adjacent non-cancerous matched tissues (margin), as well as in OSCC cell lines. Analysis of microarray data revealed the expression of 147 homeobox genes, including one set of six at least 2-fold up-regulated, and another set of 34 at least 2-fold down-regulated homeobox genes in OSCC. After qRT-PCR assays, the three most up-regulated homeobox genes (HOXA5, HOXD10 and HOXD11) revealed higher and statistically significant expression levels in OSCC samples when compared to margins. Patients presenting lower expression of HOXA5 had poorer prognosis compared to those with higher expression (P=0.03). Additionally, the status of HOXA5, HOXD10 and HOXD11 expression levels in OSCC cell lines also showed a significant up-regulation when compared to normal oral keratinocytes. Results confirm the presence of three significantly upregulated (>4-fold) homeobox genes (HOXA5, HOXD10 and HOXD11) in OSCC that may play a significant role in the pathogenesis of these tumors. Moreover, since lower levels of HOXA5 predict poor prognosis, this gene may be a novel candidate for development of therapeutic strategies in OSCC.


Asunto(s)
Biomarcadores de Tumor/genética , Carcinoma de Células Escamosas/genética , Proteínas de Homeodominio/genética , Neoplasias de la Boca/genética , Adulto , Anciano , Biomarcadores de Tumor/metabolismo , Carcinoma de Células Escamosas/metabolismo , Carcinoma de Células Escamosas/patología , Línea Celular Tumoral , Perfilación de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Proteínas de Homeodominio/metabolismo , Humanos , Persona de Mediana Edad , Neoplasias de la Boca/metabolismo , Neoplasias de la Boca/patología , Pronóstico , Tasa de Supervivencia
4.
Oncol Rep ; 21(3): 649-63, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-19212623

RESUMEN

Laryngeal squamous cell carcinoma is very common in head and neck cancer, with high mortality rates and poor prognosis. In this study, we compared expression profiles of clinical samples from 13 larynx tumors and 10 non-neoplastic larynx tissues using a custom-built cDNA microarray containing 331 probes for 284 genes previously identified by informatics analysis of EST databases as markers of head and neck tumors. Thirty-five genes showed statistically significant differences (SNR > or = | 1.0 |, p< or =0.001) in the expression between tumor and non-tumor larynx tissue samples. Functional annotation indicated that these genes are involved in cellular processes relevant to the cancer phenotype, such as apoptosis, cell cycle, DNA repair, proteolysis, protease inhibition, signal transduction and transcriptional regulation. Six of the identified transcripts map to intronic regions of protein-coding genes and may comprise non-annotated exons or as yet uncharacterized long ncRNAs with a regulatory role in the gene expression program of larynx tissue. The differential expression of 10 of these genes (ADCY6, AES, AL2SCR3, CRR9, CSTB, DUSP1, MAP3K5, PLAT, UBL1 and ZNF706) was independently confirmed by quantitative real-time RT-PCR. Among these, the CSTB gene product has cysteine protease inhibitor activity that has been associated with an antimetastatic function. Interestingly, CSTB showed a low expression in the tumor samples analyzed (p<0.0001). The set of genes identified here contribute to a better understanding of the molecular basis of larynx cancer, and provide candidate markers for improving diagnosis, prognosis and treatment of this carcinoma.


Asunto(s)
Biomarcadores de Tumor/genética , Carcinoma de Células Escamosas/genética , Perfilación de la Expresión Génica , Neoplasias Laríngeas/genética , Adulto , Anciano , Carcinoma de Células Escamosas/patología , Femenino , Humanos , Neoplasias Laríngeas/patología , Masculino , Persona de Mediana Edad , Análisis de Secuencia por Matrices de Oligonucleótidos , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa
5.
J Biochem Mol Biol ; 39(2): 216-22, 2006 Mar 31.
Artículo en Inglés | MEDLINE | ID: mdl-16584638

RESUMEN

In the present study, we compared six different solubilization buffers and optimized two-dimensional electrophoresis (2-DE) conditions for human lymph node proteins. In addition, we developed a simple protocol for 2-D gel storage. Efficient solubilization was obtained with lysis buffers containing (a) 8 M urea, 4% CHAPS (3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate), 40 mM Tris base, 65 mM DTT (dithiothreitol) and 0.2% carrier ampholytes; (b) 5 M urea, 2 M thiourea, 2% CHAPS, 2% SB 3-10 (N-decyl-N,N-dimethyl-3-ammonio-1-propanesulfonate), 40 mM Tris base, 65 mM DTT and 0.2% carrier ampholytes or (c) 7 M urea, 2 M thiourea, 4% CHAPS, 65 mM DTT and 0.2% carrier ampholytes. The optimal protocol for isoelectric focusing (IEF) was accumulated voltage of 16,500 Vh and 0.6% DTT in the rehydration solution. In the experiments conducted for the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), best results were obtained with a doubled concentration (50 mM Tris, 384 mM glycine, 0.2% SDS) of the SDS electrophoresis buffer in the cathodic reservoir as compared to the concentration in the anodic reservoir (25 mM Tris, 192 mM glycine, 0.1% SDS). Among the five protocols tested for gel storing, success was attained when the gels were stored in plastic bags with 50% glycerol. This is the first report describing the successful solubilization and 2D-electrophoresis of proteins from human lymph node tissue and a 2-D gel storage protocol for easy gel handling before mass spectrometry (MS) analysis.


Asunto(s)
Carcinoma de Células Escamosas/química , Electroforesis en Gel Bidimensional/métodos , Neoplasias de Cabeza y Cuello/química , Ganglios Linfáticos/química , Proteínas/análisis , Tampones (Química) , Células , Detergentes/química , Electroforesis en Gel Bidimensional/normas , Humanos , Focalización Isoeléctrica , Proteínas de Neoplasias/análisis , Solubilidad , Tiempo
6.
Rev. Soc. Bras. Fonoaudiol ; 11(4): 279-283, 2006. tab
Artículo en Portugués | LILACS | ID: lil-455174

RESUMEN

O objetivo deste estudo foi verificar a evolução clínica fonoaudiológica nos aspectos de deglutição e fonoarticulação de um paciente do sexo masculino, com idade de 56 anos, submetido à Laringectomia Near Total(LNT) associada à operação composta. A avaliação fonoaudiológica realizada no 15º pós-operatório revelou: diminuição dos movimentos de língua, de bochechas e de mandíbula, ressecção do palato mole à direita, qualidade vocal rugosa-molhada nível 2, soprosa 2, tensa 2 e instável 3, pitch adequado, loudness reduzida e inteligibilidade de fala muito comprometida. O paciente apresentava disfagia nível 3, classificada de acordo com a escala de severidade, fazendo uso da sonda nasoenteral. Iniciou tratamento fonoaudiológico para o restabelecimento da alimentação via oral e melhora da fonoarticulação. Após fonoterapia, a deglutição do paciente se tornou funcional (nível 6), com a retirada da sonda nasoenteral. Houve redução do comprometimento da inteligibilidade de fala e da qualidade vocal. A loudness e o pitch encontravam-se adequados. A média da freqüência fundamental para a vogal /a/ foi de 81,89Hz, para vogal /i/, 92,86Hz e para vogal /u/, 262,90 Hz. A fonoterapia contribuiu para a melhora da comunicação oral e da deglutição do paciente, porém o tempo de reabilitação foi prolongado devido à intercorrências durante o processo terapêutico.


Asunto(s)
Humanos , Masculino , Trastornos de la Articulación , Trastornos de Deglución , Laringectomía , Inteligibilidad del Habla , Sistema Estomatognático
7.
Rev. bras. cir. cabeça pescoço ; 18(2/3): 81-3, 1994. ilus, tab
Artículo en Portugués | LILACS | ID: lil-186220

RESUMEN

O ramo mandibular do nervo facial inerva os músculos depressor da rima bucal e depressor do lábio inferior. Procedimentos que abordam a regiao submandibular podem lesá-lo, o que leva ao desvio da rima labial e conseqüente deformaçao da estética facial. Neste estudo foram analisados quarenta ramos mandibulares do nervo facial em vinte cadáveres dissecados, demonstrando sua freqüente representaçao por mais de um ramo, a presença de anastomoses com outros ramos e sua distância de até treze milímetros da borda inferior da mandíbula.


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Mandíbula/anatomía & histología , Mandíbula/inervación , Anastomosis Arteriovenosa , Disección , Nervio Facial/anatomía & histología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...